Medical News

---

• Gender differences in adolescent atopic and nonatopic rhinitis rates
• No cancer risk with ARBs, FDA concludes
• No cancer risk with ARBs, FDA concludes
• Low colonoscopic surveillance among IBD patients with longstanding colitis
• No cancer risk with ARBs, FDA concludes
• Neurological soft signs linked to brain structure alterations in schizophrenia
• ‘Striking’ stroke mortality inequalities across Europe, Central Asia
• Improved HF therapy use could prevent ‘substantial number’ of deaths
• Diagnostic shift common after FEP
• Oral Health ‘poor’ in schizophrenia patients
• Cholesterol levels linked to impulsivity in patients with mood symptoms
• Depression symptoms common in schizophrenia patients
• Mood state linked to differences in gray matter density in BD patients
• Persistent cannabis use linked to poor outcomes in teens with FEP
• BD I patients and their relatives show maladaptive emotion regulation strategies

Gender differences in adolescent atopic and nonatopic rhinitis rates Posted: 12 Jun 2011 05:00 PM PDT Boys are more likely to develop atopic rhinitis during adolescence than girls, while girls are more likely to develop nonatopic rhinitis, results from a UK study show.

No cancer risk with ARBs, FDA concludes Posted: 12 Jun 2011 05:00 PM PDT The US Food and Drug Administration has concluded that there is no increased risk for cancer associated with ARB use, after conducting a safety review of the drug class.

No cancer risk with ARBs, FDA concludes Posted: 12 Jun 2011 05:00 PM PDT The US Food and Drug Administration has concluded that there is no increased risk for cancer associated with ARB use, after conducting a safety review of the drug class.

Low colonoscopic surveillance among IBD patients with longstanding colitis Posted: 12 Jun 2011 05:00 PM PDT Study findings show that only half of inflammatory bowel disease patients with longstanding extensive colitis undergo surveillance colonoscopy over a 3-year period.

No cancer risk with ARBs, FDA concludes Posted: 12 Jun 2011 05:00 PM PDT The US Food and Drug Administration has concluded that there is no increased risk for cancer associated with ARB use, after conducting a safety review of the drug class.

Neurological soft signs linked to brain structure alterations in schizophrenia Posted: 09 Jun 2011 05:00 PM PDT Structural alterations in the cerebello-thalamo-prefrontal network are associated with neurological soft signs in patients with schizophrenia, research shows.

‘Striking’ stroke mortality inequalities across Europe, Central Asia Posted: 09 Jun 2011 05:00 PM PDT Trends in stroke mortality in European and Central Asian countries over the past 15 years vary according to their World Health Organization demographic categories, research shows.

Improved HF therapy use could prevent ‘substantial number’ of deaths Posted: 09 Jun 2011 05:00 PM PDT Tens of thousands of deaths from heart failure in the USA could be prevented by optimal implementation of six evidence-based therapies, research suggests.

Diagnostic shift common after FEP Posted: 09 Jun 2011 05:00 PM PDT Around a fifth of patients who have suffered a first episode of psychosis have their diagnosis changed at the time of recurrence, research shows.

Oral Health ‘poor’ in schizophrenia patients Posted: 08 Jun 2011 05:00 PM PDT Patients with schizophrenia have significantly worse oral health than individuals without the mental health disorder, show Spanish study results.

Cholesterol levels linked to impulsivity in patients with mood symptoms Posted: 08 Jun 2011 05:00 PM PDT Low cholesterol levels are associated with an increased risk for attentional impulsivity in patients with mood symptoms, study results show.

Depression symptoms common in schizophrenia patients Posted: 07 Jun 2011 05:00 PM PDT Symptoms of depression are common in patients with stable schizophrenia who have not been previously been diagnosed with the mood condition, results from a Spanish study show.

Mood state linked to differences in gray matter density in BD patients Posted: 07 Jun 2011 05:00 PM PDT Results from a preliminary US study suggest that patients with bipolar disorder display differences in gray matter density according to mood state.

Persistent cannabis use linked to poor outcomes in teens with FEP Posted: 06 Jun 2011 05:00 PM PDT Persistent cannabis use is associated with poor outcomes in adolescents with first-episode psychosis, study results show.

BD I patients and their relatives show maladaptive emotion regulation strategies Posted: 06 Jun 2011 05:00 PM PDT Patients with bipolar I disorder and their unaffected relatives exhibit more frequent use of maladaptive emotion regulation strategies compared with mentally healthy individuals without such a family history, research shows.

You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 20 West Kinzie, Chicago IL USA 60610